List view / Grid view

Drug Development

Filter the results

 

article

Comparison of new vaccine approaches – COVID-19

26 June 2020 | By

The promise of virally vectored DNA and mRNA vaccines is tremendous in terms of vaccine safety and speed of response to new pathogens. This article explores why these approaches have attracted attention in light of the COVID-19 pandemic and why they are highly appropriate for rapid vaccine development and deployment.

article

Patents and approvals – medicines, vaccines and diagnostics for COVID-19

25 June 2020 | By , , , ,

As companies race to develop a COVID-19 vaccine, various discussions about patents and ownerships of the vaccine have occurred, especially in light of funding from various governments. This article explores the patent and regulation issues, with a focus on patent extensions and suspensions for global good.